Has Linda Daily received payments from drug or device companies?

Yes. Drug and device makers reported $1,801 in general payments to Linda Daily across 109 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Linda Daily did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Linda Daily come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Linda Daily

Family Medicine · Lancaster, SCNPI 1609860527

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $797 and has fallen 97.6% since, to $19 in 2025.

$1,801in general payments, 2019–2025

Across 109 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$202
Merck$183
Boehringer Ingelheim$174
AstraZeneca$167
Novo Nordisk$165
Pfizer$164
plus $745 from 16 others

What the payments were for

Food & beverage$1,801100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	6	$202
Merck	13	$183
Boehringer Ingelheim	10	$174
AstraZeneca	10	$167
Novo Nordisk	14	$165
Pfizer	10	$164
Lilly USA, LLC	8	$120
Amarin Pharma, Inc.	7	$108
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	6	$89
Sanofi-aventis U.S. LLC	4	$77
Dexcom, Inc.	4	$73
Mylan Specialty L.p.	4	$62
Radius Health, Inc.	2	$45
Novartis	2	$34
AbbVie	2	$31
Sunovion Pharmaceuticals Inc.	1	$19
Clarus Therapeutics Inc.	1	$18
Johnson & Johnson	1	$17
Kowa Pharmaceuticals America, Inc.	1	$14
Teva Pharmaceuticals USA, Inc.	1	$14
Edwards Lifesciences	1	$13
GSK	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AIMOVIG$122

How this compares

$1,801 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina →

Other family medicine in Lancaster

Stephen BruntonWinnsboro$1.3M
Richard WilkesMt Pleasant$216K
Andrew MartinColumbia$205K
Ada StewartColumbia$186K
Jeffrey BroderNorth Augusta$140K
Terry NagelColumbia$112K
Katherine JohnsonGreenwood$80K
Scott SmithMount Pleasant$68K
Jennifer StolinSummerville$59K
Nicholas PenningsNorth Myrtle Beach$55K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →